Anti-Actin, clone AC-40

Anti-Actin, clone AC-40
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
NSJ-R30001 100 µg - -

3 - 10 Werktage*

755,00 €
 
0.5mg/ml with 1% BSA and 0.01% sodium azide if reconstituted with 0.2ml sterile 1XPBS. Actin, a... mehr
Produktinformationen "Anti-Actin, clone AC-40"
0.5mg/ml with 1% BSA and 0.01% sodium azide if reconstituted with 0.2ml sterile 1XPBS. Actin, a highly conserved protein, is a major component of both the cytoskeletal and contractile structures in the cell types. It varies in amount, being related to the type of differentiation and to the functional state of cells and tissues. The actins exhibit over 90% sequence homology, but each isoform has a unique NH2-terminal sequence. The isoforms are comprised of three alpha-actin, one beta-actin, two gamma-actin. Because the amino acid sequence of the C-terminal is the same for almost all actins, this antibody has been raised using a synthetic peptide corresponding to the C-terminal 11 residues. Protein function: Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. [The UniProt Consortium]
Schlagworte: Anti-ACTA, Anti-ACTA1, Anti-Alpha-actin-1, Anti-Actin, alpha skeletal muscle, Actin Antibody
Hersteller: NSJ Bioreagents
Hersteller-Nr: R30001

Eigenschaften

Anwendung: WB, IF
Antikörper-Typ: Monoclonal
Klon: AC-40
Konjugat: No
Wirt: Mouse
Spezies-Reaktivität: human, mouse, rat, chicken
Immunogen: An Actin C-terminal peptide (SGPSIVHRKCF) was used as the immunogen for this Actin antibody.
Format: Purified

Handhabung & Sicherheit

Lagerung: +4°C
Versand: +4°C (International: +4°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Anti-Actin, clone AC-40"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen